Sign in
0M3O Stock Price, Chart, Stats & News
Zogenix, Inc.
Save
Zogenix, Inc. (0M3O) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
0M3O chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Zogenix, Inc. is a biopharmaceutical enterprise focused on discovering and bringing to market medical treatments within the United States. Its primary objective is to profoundly improve the well-being of patients and their families dealing with rare diseases. The company's most advanced product in development is Fintepla, a low-dose variant of fenfluramine.
Similar securities
Based on sector and market capitalization
Report issue